ロード中...

Impact of Bone-targeted Therapies in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer Patients Treated with Abiraterone Acetate: Post Hoc Analysis of Study COU-AA-302

BACKGROUND: Metastatic castration-resistant prostate cancer (mCRPC) often involves bone, and bone-targeted therapy (BTT) has become part of the overall treatment strategy. OBJECTIVE: Investigation of outcomes for concomitant BTT in a post hoc analysis of the COU-AA-302 trial, which demonstrated an o...

詳細記述

保存先:
書誌詳細
出版年:Eur Urol
主要な著者: Saad, Fred, Shore, Neal, Van Poppel, Hendrik, Rathkopf, Dana E., Smith, Matthew R., de Bono, Johann S., Logothetis, Christopher J., de Souza, Paul, Fizazi, Karim, Mulders, Peter F.A., Mainwaring, Paul, Hainsworth, John D., Beer, Tomasz M., North, Scott, Fradet, Yves, Griffin, Thomas A., De Porre, Peter, Londhe, Anil, Kheoh, Thian, Small, Eric J., Scher, Howard I., Molina, Arturo, Ryan, Charles J.
フォーマット: Artigo
言語:Inglês
出版事項: 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5056561/
https://ncbi.nlm.nih.gov/pubmed/25985882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2015.04.032
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!